{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:02:36Z","timestamp":1790283756489,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T00:00:00Z","timestamp":1715472000000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R01-AI095066"],"award-info":[{"award-number":["R01-AI095066"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcv.2023.105491","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T11:23:45Z","timestamp":1683372225000},"page":"105491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing"],"prefix":"10.1016","volume":"164","author":[{"given":"Gina","family":"Faraci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Dub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7260-2383","authenticated-orcid":false,"given":"Ha Youn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2023.105491_bib0001","unstructured":"UNAIDS. Global HIV & AIDS statistics - Fact sheet. 2021."},{"issue":"5","key":"10.1016\/j.jcv.2023.105491_bib0002","first-page":"572","article-title":"Virologic failure among people living with HIV initiating dolutegravir-based versus other recommended regimens in real-world clinical care settings","volume":"81","author":"Nance","year":"2019","journal-title":"JAIDS-J. Acq. Imm. Def."},{"issue":"3","key":"10.1016\/j.jcv.2023.105491_bib0003","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dku426","article-title":"Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing","volume":"70","author":"Cozzi-Lepri","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.jcv.2023.105491_bib0004","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/QAI.0b013e3181ba11e8","article-title":"Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy","volume":"52","author":"Geretti","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.jcv.2023.105491_bib0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAD.0b013e3283427dcb","article-title":"Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy","volume":"25","author":"Goodman","year":"2011","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.jcv.2023.105491_bib0006","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy","volume":"5","author":"Johnson","year":"2008","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.jcv.2023.105491_bib0007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients","volume":"48","author":"Metzner","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2023.105491_bib0008","first-page":"662","article-title":"Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure","volume":"201","author":"Paredes","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2023.105491_bib0009","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes","volume":"199","author":"Simen","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"19","key":"10.1016\/j.jcv.2023.105491_bib0010","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130118","article-title":"Linked dual-class HIV resistance mutations are associated with treatment failure","volume":"4","author":"Boltz","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jcv.2023.105491_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000001273","article-title":"Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern","volume":"31","author":"Muri","year":"2017","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.jcv.2023.105491_bib0012","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/cid\/cis254","article-title":"Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies","volume":"54","author":"Hamers","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jcv.2023.105491_bib0013","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/QAI.0b013e31827b4ac8","article-title":"Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy","volume":"62","author":"Wamalwa","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.jcv.2023.105491_bib0014","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.7448\/IAS.15.2.17985","article-title":"Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon","volume":"15","author":"Liegeois","year":"2012","journal-title":"J. Int. AIDS Soc."},{"issue":"11","key":"10.1016\/j.jcv.2023.105491_bib0015","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/jac\/dky300","article-title":"Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa","volume":"73","author":"Fofana","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.jcv.2023.105491_bib0016","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/v10020060","article-title":"High levels of dual-class drug resistance in HIV-infected children failing first-line antiretroviral therapy in Southern Ethiopia","volume":"10","author":"Tadesse","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jcv.2023.105491_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-6405-11-3","article-title":"Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort","volume":"11","author":"Pillay","year":"2014","journal-title":"AIDS Res. Ther."},{"issue":"1","key":"10.1016\/j.jcv.2023.105491_bib0018","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis","volume":"43","author":"Palmer","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"suppl_9","key":"10.1016\/j.jcv.2023.105491_bib0019","doi-asserted-by":"crossref","first-page":"S847","DOI":"10.1093\/infdis\/jix430","article-title":"The role of HIV-1 drug-resistant minority variants in treatment failure","volume":"216","author":"Stella-Ascariz","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2023.105491_bib0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/655397","article-title":"Minority variants of drug-resistant HIV","volume":"202","author":"Gianella","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"suppl_9","key":"10.1016\/j.jcv.2023.105491_bib0021","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1093\/infdis\/jix397","article-title":"Next-generation human immunodeficiency virus sequencing for patient management and drug resistance surveillance","volume":"216","author":"Noguera-Julian","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2023.105491_bib0022","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41598-020-58544-z","article-title":"Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jcv.2023.105491_bib0023","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/v12080850","article-title":"Fact and fiction about 1%: next generation sequencing and the detection of minor drug resistant variants in HIV-1 populations with and without unique molecular identifiers","volume":"12","author":"Zhou","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.jcv.2023.105491_bib0024","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/infdis\/jiab060","article-title":"Microdrop human immunodeficiency virus sequencing for incidence and drug resistance surveillance","volume":"224","author":"Park","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2023.105491_bib0025","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1128\/JVI.03128-13","article-title":"Developing high-throughput HIV incidence assay with pyrosequencing platform","volume":"88","author":"Park","year":"2014","journal-title":"J. Virol."},{"issue":"14","key":"10.1016\/j.jcv.2023.105491_bib0026","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/nar\/gkf436","article-title":"MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform","volume":"30","author":"Katoh","year":"2002","journal-title":"Nucleic. Acids. Res."},{"issue":"3","key":"10.1016\/j.jcv.2023.105491_bib0027","doi-asserted-by":"crossref","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","article-title":"FastTree 2\u2013approximately maximum-likelihood trees for large alignments","volume":"5","author":"Price","year":"2010","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jcv.2023.105491_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12977-016-0321-6","article-title":"Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA","volume":"13","author":"Boltz","year":"2016","journal-title":"Retrovirology"},{"issue":"50","key":"10.1016\/j.jcv.2023.105491_bib0029","doi-asserted-by":"crossref","first-page":"20166","DOI":"10.1073\/pnas.1110064108","article-title":"Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID","volume":"108","author":"Jabara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.jcv.2023.105491_bib0030","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/infdis\/jiy426","article-title":"Using primer-ID deep sequencing to detect recent human immunodeficiency virus type 1 infection","volume":"218","author":"Dennis","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"22","key":"10.1016\/j.jcv.2023.105491_bib0031","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1128\/JVI.74.22.10707-10713.2000","article-title":"Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors","volume":"74","author":"Winters","year":"2000","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.jcv.2023.105491_bib0032","doi-asserted-by":"crossref","first-page":"e02011","DOI":"10.1128\/jvi.02011-21","article-title":"Plasma-derived HIV-1 virions contain considerable levels of defective genomes","volume":"96","author":"Fisher","year":"2022","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.jcv.2023.105491_bib0033","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QAI.0b013e3181bca669","article-title":"Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors","volume":"52","author":"Varghese","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"11","key":"10.1016\/j.jcv.2023.105491_bib0034","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/JVI.06541-11","article-title":"Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen","volume":"86","author":"Fisher","year":"2012","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.jcv.2023.105491_bib0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/jix338","article-title":"Prevalence of drug-resistant minority variants in untreated HIV-1-infected individuals with and those without transmitted drug resistance detected by sanger sequencing","volume":"216","author":"Clutter","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2023.105491_bib0036","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcv.2012.06.018","article-title":"Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection","volume":"55","author":"Nicot","year":"2012","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.jcv.2023.105491_bib0037","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0092-8674(76)90055-6","article-title":"A colony bank containing synthetic Col El hybrid plasmids representative of the entire E. coli genome","volume":"9","author":"Clarke","year":"1976","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2023.105491_bib0038","series-title":"Essential Microbiology","author":"Hogg","year":"2013"},{"issue":"6","key":"10.1016\/j.jcv.2023.105491_bib0039","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cid\/ciab583","article-title":"Transmitted drug resistance among Human Immunodeficiency Virus (HIV)-1 diagnoses in the United States, 2014-2018","volume":"74","author":"McClung","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2023.105491_bib0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"Wittkop","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2023.105491_bib0041","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/cid\/ciy453","article-title":"Trends in the molecular epidemiology and genetic mechanisms of transmitted human immunodeficiency virus type 1 drug resistance in a large US clinic population","volume":"68","author":"Rhee","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"18","key":"10.1016\/j.jcv.2023.105491_bib0042","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/nar\/24.18.3546","article-title":"PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases","volume":"24","author":"Cline","year":"1996","journal-title":"Nucleic. Acids. Res."},{"issue":"9","key":"10.1016\/j.jcv.2023.105491_bib0043","article-title":"Extensive recombination due to heteroduplexes generates large amounts of artificial gene fragments during PCR","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223001142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223001142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:33:06Z","timestamp":1790281986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653223001142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":43,"alternative-id":["S1386653223001142"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105491","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105491"}}